Results 251 to 260 of about 10,318 (317)

Comparative Effectiveness of SGLT2i and GLP-1RA on Blood Pressure in Hypertensive Patients with Type 2 Diabetes: A Saudi Multicenter Retrospective Study. [PDF]

J Clin Med
Alshehri G, Alrashidi R, Alhaqbani R, Almeshari R, Bin Sheraim N, Alharbi A, Al Yami MS, Alanazi A, Alsalamah N, Alrossies A.   +9 more
europepmc   +1 more source

Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. [PDF]

Biomedicines
Wang W, Green D, Ibrahim R, Abdelnabi M, Pham HN, Forst B, Allam M, Sarkis P, Bcharah G, Farina J, Ayoub C, Sorajja D, Arsanjani R.   +12 more
europepmc   +1 more source

Effects of GLP-1RA Treatment on Long-Term Post-PCI Prognosis in T2DM Patients: A Propensity Score Matching Study. [PDF]

Diabetes Metab Syndr Obes
Fang B, Liu F, Luo J, Song N, Liu C, Ji W, An X, Xie Q, Yang Y, Li X.   +9 more
europepmc   +1 more source

Identifying High-Risk Obese Individuals Without Diabetes for GLP-1RA Therapy Using Coronary CTA. [PDF]

JACC Adv
Blair CV, Huck D, Besser SA, Cardoso R, Shiyovich A, Berman AN, Biery DW, Weber BN, Petranovic M, Nasir K, Hedgire S, Plutzky J, Cannon C, Di Carli MF, Ghoshhajra BB, Trinquart L, Blankstein R.   +16 more
europepmc   +1 more source

Risk of Urogenital Infections in People with Type 2 Diabetes Initiating SGLT2i versus GLP-1RA in Routine Clinical Care: A Danish Cohort Study

Christine Ljungberg, F. Kristensen, Michael Dalager‐Pedersen, Christina M. J. E. Vandenbroucke‐Grauls, Henrik Toft Sørensen, Mette Nørgaard, Reimar W. Thomsen   +6 more
openalex   +1 more source

The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management [PDF]

Blair Suter, Allison Rhodes, Allison Bigeh, Timothy C. Frommeyer, Laxmi S. Mehta   +4 more
openalex   +1 more source

Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods. [PDF]

Cardiovasc Diabetol
Morieri ML, Longato E, Sciannameo V, Donatiello E, Berchialla P, Avogaro A, Consoli A, Fadini GP.   +7 more
europepmc   +1 more source

Missed Doses, Missed Opportunities: Readmission Due to GLP-1RA Interruption Inspires Algorithms to Improve Reinitiation of Therapy at Discharge. [PDF]

Hosp Pharm
Michelet A, Mowla M, Amo-Brown BA, Rodriguez N, Cavaretta M.   +4 more
europepmc   +1 more source

GLP-1RA Exposure and Nonarteritic Anterior Ischemic Optic Neuropathy Prevalence by Diabetes Status

Pallavi Nagdeve, Russell Griffin
openalex   +2 more sources

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes. [PDF]

Front Cardiovasc Med
Agarwal S, Basit MA, Bowen ME, Heitjan DF, Mai C, Marble K, Pak J, Xiang Z, Lingvay I.   +8 more
europepmc   +1 more source